- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05811819
Hand Training & Brain Changes
March 31, 2023 updated by: IRegained Inc.
Reversing Physiological Dysfunction With Non-invasive Brain Stimulation: Physiological Changes From Hand Movement Therapy
10 participants with upper-limb impairment will be recruited from community sources.
They will be invited to participate in a 15-day trial involving the IRegained device.
The study will involve 2 assessment visits to McMaster, before and after the treatment, and 15 treatment visits.
The data from the pilot study will be analyzed both quantitatively and qualitatively, as outcomes and explicit feedback from participants will be used to further optimize the device for future studies.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This pilot study will investigate the potential changes in the brain area controlling hand movement following 15 days of exercises to improve hand function in participants with upper limb impairments resulting from stroke.
A device developed by Dr. Vineet Johnson (IRegained Inc.) will be used to administer standardized exercises to improve hand function.
To assess brain changes, transcranial magnetic stimulation pulses will be delivered to the motor cortex.
The motor evoked potential (MEP), a muscle response evoked from the TMS, will be measured using electrodes on the hand.
This study will test the feasibility of conducting motor therapy using this device while assessing potential changes in motor cortex function.
Findings from this study will contribute to developing treatment trials aimed at improving impaired limb function in stroke patients and quality of life in these individuals
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ravjot Rehsi, MSc
- Phone Number: 9052996418
- Email: rehsir@mcmaster.ca
Study Contact Backup
- Name: Mikayla Marshall
- Phone Number: 2898088821
- Email: mikayla@iregained.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8L 8E7
- Recruiting
- Aimee Nelson
-
Contact:
- Mikayla Marshall
- Phone Number: 2898088821
- Email: mikayla@iregained.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
-Sustained a single stroke >6months prior to start of study
Exclusion Criteria:
- Severe spasticity or contractures (2 or less in the CMSA)
- any other musculoskeletal or neuromuscular disorders that compromise sensation
- Prospective participants who are incapable of providing consent to participate in the research study will also be excluded (determined by an MMSE score of 23 or less).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Neurorehabilitation of the Hand
Participants will undergo a 1-hour training session 5 days per week, over 3 weeks for a total of 15 sessions.
Hand function therapy will be administered using the gamified protocol to enhance rehabilitation of the hand and provide participants with greater opportunity to regain hand function over the course of the study.
|
Participants will undergo three weeks of 1-hour hand therapy with the MyHand System.
The MyHand System provides a highly unique and targeted approach to hand function rehabilitation with the help of the aforementioned protocols delivered with gamified training techniques.
The gamified format of the protocols allows for better patient engagement, thus allowing for more effective and efficient therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chedoke Arm and Hand Activity Inventory 9 (CAHAI-9)- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
a 9-item assessment, will be performed by a trained clinician to estimate a participants functional ability during the initial assessment.
The CAHAI-9 requires a participant to perform 9 bimanual ADLs, each of which will be scored on a 7 point scale.
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
ABILHAND- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
a subjective functional assessment tool will be used.
The tool is a 23-item survey, and participants are provided with a list of various everyday functional tasks and are scored based on patient response.
For example, participant will be asked whether it is 'easy', 'difficult' or 'impossible' for each of the 23 tasks.
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Box and Block (BBT)- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
The BBT requires participants to move cubical wooden blocks over a partition from one box to another.
Grip and pinch dynamometry will be used to assess a participant's hand strength.
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Finger Goniometry- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Estimate range of motion (ROM) of the various finger joints.
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Grip Dynamometry- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Measures participants grip strength
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Pinch Dynamometry- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Measures participants pinch strength
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Aimee Nelson, PhD, McMaster University
- Study Director: Jed Meltzer, PhD, Baycrest Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 19, 2022
Primary Completion (Anticipated)
July 9, 2023
Study Completion (Anticipated)
July 9, 2023
Study Registration Dates
First Submitted
September 28, 2022
First Submitted That Met QC Criteria
March 31, 2023
First Posted (Actual)
April 13, 2023
Study Record Updates
Last Update Posted (Actual)
April 13, 2023
Last Update Submitted That Met QC Criteria
March 31, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BHMU0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Treatment using the MyHand System
-
IRegained Inc.McMaster University; BaycrestCompleted
-
IRegained Inc.Laurentian University, Health Science NorthRecruitingStroke | Engagement, PatientCanada
-
Galvanize Therapeutics, Inc.TerminatedCancer of Lung, Kidney or LiverHong Kong, Spain, Netherlands
-
Ra Medical SystemsTerminatedPeripheral Artery DiseaseUnited States
-
IRegained Inc.Laurentian University; Health Sciences NorthCompleted
-
Indiana UniversityActive, not recruitingLung Cancer | Metastatic CancerUnited States
-
HistoSonics, Inc.Not yet recruitingThe HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy (GANNON)Pancreatic Cancer | Pancreas Cancer | Adenocarcinoma of the Pancreas | Tumor of PancreasSpain
-
Galvanize Therapeutics, Inc.Active, not recruitingNon Small Cell Lung CancerHong Kong, Spain, Netherlands
-
Medical University of GrazMenarini GroupCompleted
-
Fondazione Bruno KesslerDentsply Sirona Implants and ConsumablesRecruitingEdentulous Alveolar Ridge | Alveolar Bone ResorptionItaly